Evidence map›Paper›PMID 38652090›Full record

Trial reportEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2024

Personalized pulmonary vein isolation with very high-power short-duration lesions guided by left atrial wall thickness: the QDOT-by-LAWT randomized trial.

Giulio Falasconi, Diego Penela, David Soto-Iglesias, Pietro Francia, Andrea Saglietto, Dario Turturiello, Daniel Viveros, Aldo Bellido, Jose Alderete, Fatima Zaraket and 7 more

Registry-linked trialAbstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04298177 (Personalized Atrial Fibrillation Ablation With the QDOT Catheter - The QDOT-by-LAW Trial), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04298177 phase4unknown statusnot on this map

Personalized Atrial Fibrillation Ablation With the QDOT Catheter - The QDOT-by-LAW Trial

TypeinterventionalSponsorAntonio Berruezo, MD, PhDRan2022 to 2023Enrolled77ConditionsAtrial FibrillationArmsAtrial fibrillation ablation using the QDOT® catheter, Standard atrial fibrillation ablation
3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Personalized pulmonary vein isolation guided by left atrial wall thickness for persistent atrial fibrillation ablation: the PeAF-by-LAWT randomized trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  2. Very high-power short-duration using 70W and a flexible tip ablation catheter for pulmonary vein isolation: the POWER PULSE randomized controlled trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  3. Using computed tomography atrial myocardial thickness maps in cryoballoon pulmonary vein isolation: the UTMOST AF II randomized clinical trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Left atrial intramyocardial fat at pulmonary vein reconnection sites during atrial fibrillation redo ablation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. The Ablate-by-LAWT multicentre prospective study: Personalized paroxysmal atrial fibrillation ablation with ablation index adapted to local left atrial wall thickness.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Giulio FalasconiHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0001-7128-9911
Diego PenelaHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0009-0009-7221-4829
David Soto-IglesiasHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0003-1394-6260
Pietro FranciaHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0003-0306-7764
Andrea SagliettoHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0001-9475-1507
Dario TurturielloHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.
Daniel ViverosHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0002-8317-561X
Aldo BellidoHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.
Jose AldereteHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0003-0318-5349
Fatima ZaraketHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0002-0706-1987
Paula Franco-OcañaHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0002-6157-058X
Marina HuguetHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0002-3524-6612
Óscar CámaraPompeu Fabra University, Barcelona, Spain.ORCID 0000-0002-5125-6132
Radu VătășescuFaculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0001-7163-8528
José-Tomás Ortiz-PérezHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0001-8043-6055
Julio Martí-AlmorHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0001-9927-1190
Antonio BerruezoHeart Institute, Teknon Medical Centre, Calle Villana 12, 08022 Barcelona, Spain.ORCID 0000-0002-5418-383X

Funding

Biosense Webster IIS-592
6 · The paper itself

Abstract

aimsPulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) using very high-power short-duration (vHPSD) radiofrequency (RF) ablation proved to be safe and effective. However, vHPSD applications result in shallower lesions that might not be always transmural. Multidetector computed tomography-derived left atrial wall thickness (LAWT) maps could enable a thickness-guided switching from vHPSD to the standard-power ablation mode. The aim of this randomized trial was to compare the safety, the efficacy, and the efficiency of a LAWT-guided vHPSD PVI approach with those of the CLOSE protocol for PAF ablation (NCT04298177). METHODS AND

resultsConsecutive patients referred for first-time PAF ablation were randomized on a 1:1 basis. In the QDOT-by-LAWT arm, for LAWT ≤2.5 mm, vHPSD ablation was performed; for points with LAWT > 2.5 mm, standard-power RF ablation titrating ablation index (AI) according to the local LAWT was performed. In the CLOSE arm, LAWT information was not available to the operator; ablation was performed according to the CLOSE study settings: AI ≥400 at the posterior wall and ≥550 at the anterior wall. A total of 162 patients were included. In the QDOT-by-LAWT group, a significant reduction in procedure time (40 vs. 70 min; P < 0.001) and RF time (6.6 vs. 25.7 min; P < 0.001) was observed. No difference was observed between the groups regarding complication rate (P = 0.99) and first-pass isolation (P = 0.99). At 12-month follow-up, no significant differences occurred in atrial arrhythmia-free survival between groups (P = 0.88).

conclusionLAWT-guided PVI combining vHPSD and standard-power ablation is not inferior to the CLOSE protocol in terms of 1-year atrial arrhythmia-free survival and demonstrated a reduction in procedural and RF times.

Indexed as

Atrial FibrillationCatheter AblationHeart AtriaMultidetector Computed TomographyPulmonary VeinsAction PotentialsAgedFemaleHeart RateHumansMaleMiddle AgedRecurrenceTime FactorsTreatment OutcomeCatheter ablationLeft atrial wall thicknessMultidetector cardiac tomographyParoxysmal atrial fibrillationPulmonary vein isolationVery high-power short-duration

Identifiers

PMID38652090
PMCPMC11036893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.